Effect of Helmet Noninvasive Ventilation vs Usual Respiratory Support on Mortality Among Patients With Acute Hypoxemic Respiratory Failure Due to COVID-19

医学 2019年冠状病毒病(COVID-19) 急性呼吸衰竭 机械通风 严重急性呼吸综合征冠状病毒2型(SARS-CoV-2) 呼吸衰竭 2019-20冠状病毒爆发 重症监护医学 急诊医学 通风(建筑) 呼吸系统 内科学 病毒学 传染病(医学专业) 疾病 工程类 爆发 机械工程
作者
Yaseen M. Arabi,Sara Aldekhyl,Saad Al Qahtani,Hasan M. Al‐Dorzi,Sheryl Ann Abdukahil,Mohammed K. Al Harbi,Eman Al Qasim,Ayman Kharaba,Talal Albrahim,Mohammed Alshahrani,Abdulrahman Al‐Fares,Ali Al Bshabshe,Ahmed Mady,Zainab Al Duhailib,Haifa Algethamy,Jesna Jose,Mohammed Al Mutairi,Omar Al Zumai,Hussain Al Haji,Ahmed Alaqeily
出处
期刊:JAMA [American Medical Association]
卷期号:328 (11): 1063-1063 被引量:45
标识
DOI:10.1001/jama.2022.15599
摘要

Importance Helmet noninvasive ventilation has been used in patients with COVID-19 with the premise that helmet interface is more effective than mask interface in delivering prolonged treatments with high positive airway pressure, but data about its effectiveness are limited. Objective To evaluate whether helmet noninvasive ventilation compared with usual respiratory support reduces mortality in patients with acute hypoxemic respiratory failure due to COVID-19 pneumonia. Design, Setting, and Participants This was a multicenter, pragmatic, randomized clinical trial that was conducted in 8 sites in Saudi Arabia and Kuwait between February 8, 2021, and November 16, 2021. Adult patients with acute hypoxemic respiratory failure (n = 320) due to suspected or confirmed COVID-19 were included. The final follow-up date for the primary outcome was December 14, 2021. Interventions Patients were randomized to receive helmet noninvasive ventilation (n = 159) or usual respiratory support (n = 161), which included mask noninvasive ventilation, high-flow nasal oxygen, and standard oxygen. Main Outcomes and Measures The primary outcome was 28-day all-cause mortality. There were 12 prespecified secondary outcomes, including endotracheal intubation, barotrauma, skin pressure injury, and serious adverse events. Results Among 322 patients who were randomized, 320 were included in the primary analysis, all of whom completed the trial. Median age was 58 years, and 187 were men (58.4%). Within 28 days, 43 of 159 patients (27.0%) died in the helmet noninvasive ventilation group compared with 42 of 161 (26.1%) in the usual respiratory support group (risk difference, 1.0% [95% CI, −8.7% to 10.6%]; relative risk, 1.04 [95% CI, 0.72-1.49]; P = .85). Within 28 days, 75 of 159 patients (47.2%) required endotracheal intubation in the helmet noninvasive ventilation group compared with 81 of 161 (50.3%) in the usual respiratory support group (risk difference, −3.1% [95% CI, −14.1% to 7.8%]; relative risk, 0.94 [95% CI, 0.75-1.17]). There were no significant differences between the 2 groups in any of the prespecified secondary end points. Barotrauma occurred in 30 of 159 patients (18.9%) in the helmet noninvasive ventilation group and 25 of 161 (15.5%) in the usual respiratory support group. Skin pressure injury occurred in 5 of 159 patients (3.1%) in the helmet noninvasive ventilation group and 10 of 161 (6.2%) in the usual respiratory support group. There were 2 serious adverse events in the helmet noninvasive ventilation group and 1 in the usual respiratory support group. Conclusions and Relevance Results of this study suggest that helmet noninvasive ventilation did not significantly reduce 28-day mortality compared with usual respiratory support among patients with acute hypoxemic respiratory failure due to COVID-19 pneumonia. However, interpretation of the findings is limited by imprecision in the effect estimate, which does not exclude potentially clinically important benefit or harm. Trial Registration ClinicalTrials.gov Identifier: NCT04477668
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
1秒前
1秒前
2秒前
luozejun完成签到,获得积分10
2秒前
ycp完成签到,获得积分10
3秒前
dawang完成签到 ,获得积分10
3秒前
洁净的智宸完成签到 ,获得积分10
3秒前
zhaopeipei发布了新的文献求助10
3秒前
eternity136完成签到,获得积分10
3秒前
4秒前
SciGPT应助zz采纳,获得10
4秒前
科研欣路完成签到,获得积分10
5秒前
bulingbuling发布了新的文献求助10
6秒前
斯文败类应助Y123采纳,获得10
6秒前
eternity136发布了新的文献求助10
6秒前
7秒前
共享精神应助zzq778采纳,获得10
7秒前
7秒前
7秒前
小辉发布了新的文献求助10
9秒前
跳跃小伙完成签到 ,获得积分10
9秒前
9秒前
9秒前
9秒前
laber应助kento采纳,获得50
10秒前
Jackcaosky完成签到 ,获得积分10
10秒前
午夜咖啡香完成签到,获得积分20
10秒前
小二郎应助冷静采纳,获得10
11秒前
胡航航完成签到,获得积分10
11秒前
大吴克发布了新的文献求助10
13秒前
精明寒蕾完成签到,获得积分10
13秒前
A宇完成签到,获得积分10
14秒前
白兰鸽发布了新的文献求助10
14秒前
jielailai完成签到,获得积分10
14秒前
yangkunmedical完成签到,获得积分10
16秒前
斯文败类应助hahaha123213123采纳,获得10
16秒前
核桃发布了新的文献求助10
16秒前
今天你开组会了吗完成签到,获得积分10
16秒前
璐璐完成签到 ,获得积分10
17秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
Research on Disturbance Rejection Control Algorithm for Aerial Operation Robots 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038368
求助须知:如何正确求助?哪些是违规求助? 3576068
关于积分的说明 11374313
捐赠科研通 3305780
什么是DOI,文献DOI怎么找? 1819322
邀请新用户注册赠送积分活动 892672
科研通“疑难数据库(出版商)”最低求助积分说明 815029